Ignite Creation Date:
2024-05-06 @ 2:46 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04424056
Status:
UNKNOWN
Last Update Posted:
2020-06-23
First Post:
2020-06-08
Brief Title:
A Trial Using ANAKINRA TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease
Sponsor:
Assistance Publique Hopitaux De Marseille
Organization:
Assistance Publique Hopitaux De Marseille
Organization Data
Organization:
Assistance Publique Hopitaux De Marseille
Class:
OTHER
Study ID:
2020-23
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None